19 employees
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
2022
$350M
from 4 investors over 4 rounds
AreteiaTx raised $350M on July 12, 2022
Investors: Maverick Capital, GV, ARCH Venture Partners and Saturn Management